מיגרלב
Country: Israel
Language: Hebrew
Source: Ministry of Health
Patient Information leaflet
(PIL)
31-10-2016
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
BUCLIZINE HYDROCHLORIDE; CODEINE PHOSPHATE; PARACETAMOL
Available from:
MANON PHARM LTD.
ATC code:
R06AE51
Pharmaceutical form:
טבליה
Composition:
PARACETAMOL 500 MG; CODEINE PHOSPHATE 8 MG; BUCLIZINE HYDROCHLORIDE 6.25 MG
Administration route:
פומי
Prescription type:
מרשם נדרש
Manufactured by:
JANSSEN CILAG S.A., FRANCE
Therapeutic group:
BUCLIZINE, COMBINATIONS
Therapeutic area:
BUCLIZINE, COMBINATIONS
Therapeutic indications:
Treatment of migraine attacks, including accompanying symptoms: headache, nausea and vomiting.
Authorization date:
2012-09-30
Patient Information leaflet
-6-
ʭʩʧʷʥʸʤʺʥʰʷʺʩʴʬʯʫʸʶʬʯʥʬʲ
)
ʭʩʸʩʹʫʺ (
ʮʹʺʤ
"
ʥ
-
1986
ʣʡʬʡʠʴʥʸʭʹʸʮʩʴʬʲʺʷʥʥʹʮʤʴʥʸʺʤ
ʡʬʸʢʩʮ
ʺʥʩʬʡʨ
ʡʫʸʤ
:
ʤʬʩʫʮʤʩʬʡʨʬʫ
Buclizine Hydrochloride6.25 MG
ʡ
ʬʫʥʸʣʩʤʯʩʦʩʬʷʥ
ʣʩʸʥ
Codein Phosphate 8 MG
ʠʴʱʥʴʯʩʠʣʥʷ
ʨ
Paracetamol 500 MG
ʴ
ʠʸ
ʬʥʮʨʶ
ʤʠʸʸʩʹʫʺʡʭʩʬʩʲʴʩʺʬʡʤʭʩʸʮʥʧʤʺʮʩʹʸʬ
ʳʩʲʱ
6
-
"
ʳʱʥʰʲʣʩʮ
."
ʠʸʷ
/
ʹʮʺʹʺ
ʭʸʨʡ
ʥʴʥʱ
ʣʲ
ʯʥʬʲʤ ʺʠ ʯʥʩʲʡ
ʩ
ʤʴʥʸʺʡ
ʤʴʥʸʺʤʬʲʩʺʩʶʮʺʲʣʩʮʬʩʫʮʤʦʯʥʬʲ
ʺʥʴʱʥʰ ʺʥʬʠʹ ʪʬ ʹʩ ʭʠ
ʬʠ ʥʠ ʠʴʥʸʤ ʬʠ ʤʰʴ
ʧʷʥʸʤ
ʪʸʥʡʲ ʤʮʹʸʰ ʥʦ ʤʴʥʸʺ
ʭʩʸʧʠʬ ʤʺʥʠ
ʸʩʡʲʺ ʬʠ
ʭʡʶʮ ʩʫ ʪʬ ʤʠʸʰ ʭʠ ʥʬʩʴʠ ʭʤʬ ʷʩʦʤʬ
ʤʬʥʬʲ ʠʩʤ
ʤʮʥʣʩʠʥʴʸʤ
x
ʭʩʮʩʤʹʥʬʹʮʤʬʲʮʬʪʹʮʡʤʴʥʸʺʡʹʮʺʹʤʬʯʩʠ
ʭʩʴʥʶʸ
ʪʸʥʶʹʩʥʤʣʩʮʡ
ʡ
ʸʺʥʩʪʹʥʮʮʹʥʮʩʹ
ʹʩ
ʤʬ
ʩ
ʥʠʠʴʥʸʡʵʲʥʥ
ʡ
ʧʷʥʸ
x
ʺʥʸʫʮʺʤʬʭʥʸʢʬʬʥʬʲʤʯʩʠʣʥʷʤʬʩʫʮʥʦʤʴʥʸʺ
ʭʩʮʩʤʹʥʬʹʮʪʹʥʮʮʹʥʮʩʹʡ
ʺʷʱʴʤʭʲ
ʲʩʴʥʤʬʺʥʬʥʬʲʪʹʥʮʮʹʥʮʩʹʸʧʠʬʹʥʮʩʹʤ
ʤʴʥʸʺʤʮʤʬʩʮʢʺʥʲʴʥʺ
.
x
ʹʠʸʩʡʠʫʪʥʫʩʹʬʥʦʤʴʥʸʺʺʬʨʰʭʠ
ʪʹʮʡ
ʸʺʥʩ
ʭʩʮʩʤʹʥʬʹʮ
ʺʠʸʩʮʧʤʬʤʬʥʬʲʤʴʥʸʺʤ
ʭʩʡʠʫʤ
.
x
ʬʩʢʬʺʧʺʮʭʩʣʬʩʬʺʣʲʥʩʮʤʰʩʠʤʴʥʸʺʤ
12
1 .
ʤʴʥʸʺʤʺʣʲʥʩʮʤʮʬ
?
ʤʰʸʢʩʮ
ʩʴʷʺʤʡ
ʬʥʴʩʨʬ
ʺʣʲʥʩʮ
ʤʴʥʸʺʤ
ʬʬʥʫ
ʭʩʥʥʬʩʰʤʭʩʮʥʨʴʮʩʱʤ
ʹʠʸʩʡʠʫ
ʺʥʠʷʤʥʺʥʬʩʧʡ
ʺʩʨʩʩʥʴʸʺʤʶʥʡʷ
:
Buclizine Hydrochloride
-
ʯʩʮʨʱʩʤʩʨʰʠ
Codein Phosphate
-
ʺʧʴ
Read the complete document
